Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHunger that persists after starting Wegovy 0.5mg is common and, for most people, expected. The 0.5mg dose is part of a gradual titration schedule; it is not the maintenance dose, and the appetite-suppressing effect builds over weeks and months as the dose increases. If food is still on your mind more than you'd like, you are not doing anything wrong. Here is what is actually happening, and what tends to help in the meantime.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by binding to GLP-1 receptors involved in appetite signalling and gastric emptying, slowing the rate at which your stomach empties and increasing the sense of fullness after eating. That effect is real from the first dose, but it is dose-dependent. The full Wegovy treatment course begins at 0.25mg and moves through 0.5mg, 1.0mg, 1.7mg and, for many people, up to 2.4mg over several months. The 0.5mg rung of that ladder exists to let your body adjust, not to deliver the full clinical effect. The NHS semaglutide medicines page describes this titration approach clearly: the dose rises gradually to reduce side effects, and appetite reduction tends to strengthen as each new level is reached.
So if you are on 0.5mg and still thinking about food, that is not a sign the medicine is not working. It is a sign you are at an early stage of a longer process. Many people report a noticeable shift when they move to 1.0mg or above, and if you found hunger was already a challenge back on the 0.25mg starting dose, it can help to know that this pattern is genuinely common at that early stage.
The composition of your meals matters more on Wegovy than it does off it. Because the medicine reduces appetite, people sometimes eat less overall but also drift away from protein and fibre, the two food components that most reliably sustain fullness between doses. A breakfast that is mostly refined carbohydrates will leave you hungry within a couple of hours regardless of the medicine. A meal anchored by protein (eggs, fish, chicken, legumes) alongside vegetables or wholegrains tends to extend that full feeling substantially.
Fluid intake is often overlooked. Thirst and hunger signals can feel similar, and mild dehydration is one of the most reliable triggers for eating when you are not genuinely hungry. Aiming for six to eight glasses of water across the day is a practical starting point, though your individual needs vary. Our guidance on food choices while on Wegovy goes into more detail on meal composition that works alongside the medicine rather than against it.
Eating slowly helps too. GLP-1 medicines slow gastric emptying, which means the fullness signal can arrive later than it would otherwise. Eating quickly can mean you overshoot before the signal reaches you. Worth knowing before your next meal.
One thing many people notice at 0.5mg is that hunger is not constant) it follows a rough weekly rhythm. Appetite tends to be lowest in the day or two after the injection and creeps back toward the end of the week, as the medicine's concentration in your system dips. If that pattern describes you, adjusting the timing of your larger meal or a slightly higher-protein snack on day six or seven can help bridge the gap.
If hunger is persistent throughout the week rather than cyclical, or if it feels stronger than before you started, that is genuinely worth a conversation. The broader picture of hunger on Wegovy covers situations where the response is slower than expected, and there is more detail on why some people experience weaker appetite suppression even at higher doses. Questions about whether your dose should be reviewed, whether your injection technique needs checking, or whether there is something else in your medical picture that might affect the response, all of those belong with a prescriber, not a search engine. A real clinician reviews every consultation at nume; there is no algorithm in the loop. If you are already a patient, your aftercare team is reachable seven days a week via the support page.
Thinking about starting Wegovy or switching from another treatment? Our free consultation page outlines how the process works. And for a broader look at how weight-management medicines are assessed against one another, the treatment overview is a useful starting point.
One practical note: once treatment is approved, your Wegovy pen arrives in plain, unbranded packaging via tracked DPD delivery, you will get a notification on your phone the morning it is on its way. Storing it correctly (refrigerated until first use) is one of the details covered in the information that comes with it.
Hunger on 0.5mg rarely means Wegovy is the wrong treatment. It usually means the treatment is not yet at the dose where it does its main work. If you are finding that being on Wegovy but still feeling hungry is affecting your confidence in the process, that experience is well documented and worth reading about before drawing any conclusions. The STEP 1 trial, published in the New England Journal of Medicine, reported around 15% average body-weight reduction over 68 weeks at the 2.4mg maintenance dose, not at 0.5mg. The journey to that dose takes most patients four to five months of titration. Patience at this stage, combined with the food and hydration habits above, is usually the most productive thing you can do.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.